Published in J Allergy Clin Immunol on April 14, 2010
Asthma outcomes: biomarkers. J Allergy Clin Immunol (2012) 1.88
Sputum neutrophil counts are associated with more severe asthma phenotypes using cluster analysis. J Allergy Clin Immunol (2013) 1.43
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med (2014) 1.37
Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J (2011) 0.89
Characterizing asthma from a drop of blood using neutrophil chemotaxis. Proc Natl Acad Sci U S A (2014) 0.89
Galectin-10, a potential biomarker of eosinophilic airway inflammation. PLoS One (2012) 0.81
Short-term reproducibility of the inflammatory phenotype in different subgroups of adult asthma cohort. Mediators Inflamm (2015) 0.77
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study. Respir Res (2016) 0.75
The transition of sputum inflammatory cell profiles is variable in stable asthma patients. Asia Pac Allergy (2017) 0.75
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science (2004) 6.28
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients. PLoS Med (2012) 4.69
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med (2009) 3.05
The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01
Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol (2003) 2.98
Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med (2011) 2.80
T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J Allergy Clin Immunol (2009) 2.54
Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol (2009) 2.42
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol (2012) 2.24
Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol (2010) 2.17
Omalizumab for asthma in adults and children. Cochrane Database Syst Rev (2014) 2.13
Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ (2005) 2.12
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med (2009) 1.95
Injurious ventilation induces widespread pulmonary epithelial expression of tumor necrosis factor-alpha and interleukin-6 messenger RNA. Crit Care Med (2002) 1.93
Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med (2003) 1.79
Chlorine-induced injury to the airways in mice. Am J Respir Crit Care Med (2003) 1.79
Drug, patient, and physician characteristics associated with off-label prescribing in primary care. Arch Intern Med (2012) 1.78
A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. J Clin Epidemiol (2005) 1.76
Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med (2004) 1.75
Role of transforming growth factor-β in airway remodeling in asthma. Am J Respir Cell Mol Biol (2010) 1.71
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review. Ann Am Thorac Soc (2014) 1.70
Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection: a randomized trial. Ann Intern Med (2008) 1.69
IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol (2010) 1.65
Remodeling in asthma. J Allergy Clin Immunol (2011) 1.64
Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. Int J Epidemiol (2009) 1.63
S epsilon S mu and S epsilon S gamma switch circles in human nasal mucosa following ex vivo allergen challenge: evidence for direct as well as sequential class switch recombination. J Immunol (2003) 1.61
Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio (2012) 1.59
Nitric oxide in exhaled breath is poorly correlated to sputum eosinophils in patients with prednisone-dependent asthma. J Allergy Clin Immunol (2010) 1.58
Effects of written action plan adherence on COPD exacerbation recovery. Thorax (2010) 1.57
Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol (2009) 1.52
Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol (2005) 1.52
Chitinases and chitinase-like proteins in T(H)2 inflammation and asthma. J Allergy Clin Immunol (2005) 1.49
Involvement of the cysteinyl-leukotrienes in allergen-induced airway eosinophilia and hyperresponsiveness in the mouse. Am J Respir Cell Mol Biol (2003) 1.49
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. J Allergy Clin Immunol (2006) 1.44
Asthma management by monitoring sputum neutrophil count. Chest (2008) 1.44
Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol (2011) 1.44
Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol (2006) 1.43
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. J Allergy Clin Immunol (2008) 1.43
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol (2013) 1.42
An official american thoracic society statement: work-exacerbated asthma. Am J Respir Crit Care Med (2011) 1.42
Sample sizes for clinical trials using sputum eosinophils as a primary outcome. Eur Respir J (2013) 1.42
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax (2007) 1.42
Chlorine gas inhalation: human clinical evidence of toxicity and experience in animal models. Proc Am Thorac Soc (2010) 1.41
Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol (2004) 1.40
Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40
Sleep-disordered breathing in fatigued postpoliomyelitis clinic patients. Arch Phys Med Rehabil (2006) 1.39
IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts. J Allergy Clin Immunol (2006) 1.37
Probing the viscoelastic behavior of cultured airway smooth muscle cells with atomic force microscopy: stiffening induced by contractile agonist. Biophys J (2005) 1.37
Airway remodeling in asthma. Allergol Int (2007) 1.36
Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest (2007) 1.36
Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci U S A (2002) 1.33
An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection. Clin Infect Dis (2012) 1.31
Mechanisms of airway remodeling. Chest (2013) 1.30
Validity of asthma diagnoses recorded in the Medical Services database of Quebec. Pharmacoepidemiol Drug Saf (2006) 1.29
Myosin, transgelin, and myosin light chain kinase: expression and function in asthma. Am J Respir Crit Care Med (2008) 1.27
IL-9 in allergic inflammation. Int Arch Allergy Immunol (2004) 1.27
Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality. PLoS One (2013) 1.26
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol (2003) 1.23
Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report. J Aerosol Med Pulm Drug Deliv (2012) 1.20
Remodeling in asthma. Proc Am Thorac Soc (2009) 1.20
An effective strategy for diagnosing occupational asthma: use of induced sputum. Am J Respir Crit Care Med (2004) 1.19
Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol (2009) 1.18
Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol (2006) 1.17
A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol (2002) 1.16
Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa. J Allergy Clin Immunol (2005) 1.16
Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol (2004) 1.16
IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2004) 1.16
Airway remodeling in asthma. Curr Opin Pharmacol (2010) 1.16
Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. J Clin Invest (2005) 1.15
Th17-associated cytokines promote human airway smooth muscle cell proliferation. FASEB J (2012) 1.14
Smoking and asthma: clinical and radiologic features, lung function, and airway inflammation. Chest (2006) 1.12